Khoury E, Nevitt S, Madsen WR, Turtle L, Davies G, Palmieri C. Differences in outcomes and factors associated with mortality among patients with SARS-CoV-2 infection and cancer compared with those without cancer: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(5): e2210880.

Article  PubMed  PubMed Central  Google Scholar 

Tagliamento M, Agostinetto E, Bruzzone M, Ceppi M, Saini KS, de Azambuja E, Punie K, Westphalen CB, Morgan G, Pronzato P, et al. Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: a systematic review and meta-analysis. Crit Rev Oncol Hematol. 2021;163: 103365.

Article  PubMed  PubMed Central  Google Scholar 

COVID-19 vaccination in cancer patients: ESMO statements. https://www.esmo.org/covid-19-and-cancer/covid-19-vaccination.

Caswell-Jin JL, Shafaee MN, Xiao L, Liu M, John EM, Bondy ML, Kurian AW. Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population. Breast Cancer Res Treat. 2022;194(2):475–82.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Losurdo A, Lisa AVE, Tomatis M, Ponti A, Montemezzi S, Bonzano E, Fortunato L, Senonetwork Working G. Highly specialized breast centers did not experience delay of care during COVID-19 pandemic in Italy: the senonetwork experience. Breast Cancer Res Treat. 2022;196(1):87–95.

Article  PubMed  PubMed Central  Google Scholar 

Goshen-Lago T, Waldhorn I, Holland R, Szwarcwort-Cohen M, Reiner-Benaim A, Shachor-Meyouhas Y, Hussein K, Fahoum L, Baruch M, Peer A, et al. Serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer. JAMA Oncol. 2021;7(10):1507–13.

Article  PubMed  Google Scholar 

Massarweh A, Eliakim-Raz N, Stemmer A, Levy-Barda A, Yust-Katz S, Zer A, Benouaich-Amiel A, Ben-Zvi H, Moskovits N, Brenner B, et al. Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer. JAMA Oncol. 2021;7(8):1133–40.

Article  PubMed  Google Scholar 

Shmueli ES, Itay A, Margalit O, Berger R, Halperin S, Jurkowicz M, Levin EG, Levy I, Olmer L, Regev-Yochay G, et al. Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy—a single centre prospective study. Eur J Cancer. 2021;157:124–31.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cohen MJ, Oster Y, Moses AE, Spitzer A, Benenson S, Israeli-Hospitals 4th Vaccine Working G. Association of receiving a fourth dose of the BNT162b vaccine with SARS-CoV-2 infection among health care workers in Israel. JAMA Netw Open. 2022;5(8): e2224657.

Article  PubMed  PubMed Central  Google Scholar 

Pinato DJ, Aguilar-Company J, Ferrante D, Hanbury G, Bower M, Salazar R, Mirallas O, Sureda A, Plaja A, Cucurull M, et al. Outcomes of the SARS-CoV-2 omicron (B11529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study. Lancet Oncol. 2022;23(7):865–75.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Special considerations in adults and children with cancer. NIH COVID-19 treatment guidelines 2023, 2023(September 5).

Prevention and treatment of cancer-related infections. NCCN clinical practice guidelines in oncology 2023, 2023(September 5).

Curigliano G, Banerjee S, Cervantes A, Garassino MC, Garrido P, Girard N, Haanen J, Jordan K, Lordick F, Machiels JP, et al. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol. 2020;31(10):1320–35.

Article  PubMed  CAS  Google Scholar 

Mina MJ, Parker R, Larremore DB. Rethinking covid-19 Test sensitivity—a strategy for containment. N Engl J Med. 2020;383(22): e120.

Article  PubMed  CAS  Google Scholar 

Xu W, Piper-Vallillo AJ, Bindal P, Wischhusen J, Patel JM, Costa DB, Peters MLB. Time to SARS-CoV-2 clearance among patients with cancer and COVID-19. Cancer Med. 2021;10(5):1545–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lee LYW, Cazier JB, Starkey T, Briggs SEW, Arnold R, Bisht V, Booth S, Campton NA, Cheng VWT, Collins G, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309–16.

Article  PubMed  PubMed Central  CAS  Google Scholar